Grzegorz Helbig

20PUBLICATIONS
33CO-AUTHORS
Gene and molecular therapyRespiratory diseasesEnvironmental epidemiologyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 23, 2025
Benefits of primary prophylaxis with letermovir in patients after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Martyna Włodarczyk, Agata Wieczorkiewicz-Kabut, Anna Armatys

|Feb 17, 2025
Clinical Management of Persistent Hypereosinophilia.

Grzegorz Helbig, Kacper Czachor

|Jan 08, 2025
The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple Myeloma.

Anna Suska, Agata Tyczyńska, Jan Maciej Zaucha

|Dec 27, 2024
Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study.

Vikas Gupta, Ciprian Tomuleasa, Gilberto Israel Barranco Lampón

|Oct 29, 2024
Imatinib is effective in some PDGFRA/B-negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms.

Giuseppe G Loscocco, Grzegorz Helbig

|Aug 30, 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study.

Simon Renders, Maud Ngoya, Herve Finel

Pageof 4

Frequent Collaborators

2 joint publications

Anna Waszczuk-Gajda

1 joint publications

Aleksander Owczarek

1 joint publications

Przemysław J Kotyla

1 joint publications

Martyna Włodarczyk